ArticleMicrobial cell (Graz, Austria)2023

TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization.

Sylvain Thierry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.